DALLAS, Oct. 25, 2017 /PRNewswire-USNewswire/ -- Thousands will walk to end pancreatic cancer, the world's toughest cancer, at PurpleStride Dallas-Fort Worth on Nov. 11. The community event presented by Bell Nunnally & Martin LLP is hosted by the Pancreatic Cancer Action Network (PanCAN) Dallas-Fort Worth Affiliate.
![PurpleStride events raise critical funds for the mission of the Pancreatic Cancer Action Network, and give local residents the opportunity to help make strides toward a better future. With every dollar raised for PurpleStride, another patient gets vital information and resources; another researcher gets a chance at finding an early detection tool or new treatment option. Help improve patient outcomes by registering today at www.purplestride.org. PurpleStride events raise critical funds for the mission of the Pancreatic Cancer Action Network, and give local residents the opportunity to help make strides toward a better future. With every dollar raised for PurpleStride, another patient gets vital information and resources; another researcher gets a chance at finding an early detection tool or new treatment option. Help improve patient outcomes by registering today at www.purplestride.org.](https://i.ytimg.com/vi/6v-QjQn-mlI/hqdefault.jpg)
![The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve outcomes today and to double survival by 2020. (PRNewsfoto/Pancreatic Cancer Action Network)](https://mma.prnewswire.com/media/590100/PANCREATIC_CANCER_ACTION_NETWORK_LOGO.jpg?w=400)
The five-year survival rate for pancreatic cancer is just 9 percent. In order to save lives and double survival by 2020, PanCAN urges the community to join PurpleStride. Funds raised through the event support critical research, clinical initiatives and patient services, including Know Your Tumor®, Precision PromiseSM, Clinical Trial Finder and the Patient Registry.
Harley Sterns, a pancreatic cancer survivor, has made it his personal mission to improve patient outcomes since joining the local affiliate in November 2013.
"I realized that PurpleStride was a way to raise money and awareness for this terrible disease," said the 70-year-old North Richland Hills resident. "It is important to me and my family to help raise money for research so hopefully the life expectancy can increase and a cure can be found. I may not have a lot of time, but I will help however I can and continue to raise awareness for pancreatic cancer."
Texas – where more than 77,000 PanCAN supporters reside – has played an integral role in changing the course of pancreatic cancer. In fact, Texas-based researchers have received over 10 percent of the research grants PanCAN has awarded since 2003.
PurpleStride Dallas-Fort Worth will take place at Klyde Warren Park and will be hosted by CBS 11 senior investigative reporter Ginger Allen. The event is supported by national presenting sponsor Celgene, presenting sponsor Bell Nunnally & Martin LLP, national gold sponsor AbbVie, gold sponsors Methodist Digestive Institute and Ipsen Biopharmaceuticals, Inc, gold media sponsors CBS 11 & TXA 21 and iHeart DFW, silver sponsor Cherry Peterson Landry Albert LLP and bronze sponsor North Dallas Bank & Trust Co.
To register, donate or learn more about PurpleStride Dallas-Fort Worth, please visit purplestride.org/dfw.
To learn more about the Pancreatic Cancer Action Network and its signature walk PurpleStride, watch the PurpleStride PSA and the organization's PSA. Follow PanCAN on Twitter, Instagram and Facebook.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.
Media Contact:
Angeli Bateman
Media Relations Chair
Pancreatic Cancer Action Network – DFW Affiliate
[email protected]; 915-920-9711
Zahra Nealy
Public Relations Specialist
Pancreatic Cancer Action Network
[email protected]; 310-706-3532
SOURCE Pancreatic Cancer Action Network
Share this article